Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Easy-to-Use Kits Allow Rapid Identification of Microorganisms

By LabMedica International staff writers
Posted on 16 Mar 2009
Easy-to-use kits allow the accurate identification of a comprehensive range of microorganisms in just 4 hours, providing a faster and more convenient alternative to other commercially available methods.

The kit, RapID, was shown to perform significantly better than other leading commercially available systems, particularly in the identification of clinically significant yeasts and nonfermentative Gram-negative bacilli, including Burkholderia cepacia, an important pathogen in cystic fibrosis patients.

The RapID method detects preformed bacterial enzymes and is not dependent on the growth of the organism. More...
This feature allows the panels to be incubated aerobically without the need for oil overlays--resulting in further savings on time and resources.

RapID identification panels have a simple, one-step inoculation procedure. A suspect colony suspension is simply added to the inoculation tray and tipped into the test strip, inoculating each well simultaneously. Each RapID panel has the same simple procedure, allowing users to pick up the method easily without having to remember different procedures for different organism groups.

In one study RapID Yeast Plus performed significantly better than other systems in the identification of Candida krusei, which is an important pathogen of immunocompromised patients. Since this organism has an innate resistance to fluconazole, prompt identification is extremely important for appropriate therapy to be administered quickly.

In trials, the RapID method demonstrated excellent performance in the identification of oxidase negative Enterobacteriaceae, anaerobic bacteria, Gram-negative glucose non-fermenters, Corynebacterium species, yeasts, and streptococci, and related organisms. A new system is now available for the identification of staphylococci and related organisms.

The RapID systems are being offered by Oxoid (Basingstoke, UK). The RapID systems provide rapid, same-day results, compared to alternative methods that require 18-72 hours. In addition, the tests are not automated, thus allowing even smaller routine microbiology laboratories to adopt them easily.

Related Links:

Oxoid




Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.